ZLB Bioplasma Forms Pharmacist Advisory Board; Scientific Panel Conducts Inaugural Meeting at ASHP Conference.Business Editors & Health/Medical Writers GLENDALE, Calif.--(BW HealthWire)--Dec. 6, 2001 ZLB ZLB Zero Length Body ZLB Zero Length Bit Bioplasma Inc. is forming an independent IVIG IVIG Intravenous immunoglobulin, see there scientific pharmacist advisory board to assess immune medicine trends and provide strategic counsel. Jerry Siegel, R.Ph., FASHP FASHP Fellow of the American Society of Health System Pharmacists , clinical associate professor and senior director, Ohio State University Ohio State University, main campus at Columbus; land-grant and state supported; coeducational; chartered 1870, opened 1873 as Ohio Agricultural and Mechanical College, renamed 1878. There are also campuses at Lima, Mansfield, Marion, and Newark. Medical Center, will lead the scientific panel, which will consist of pharmacy experts from leading medical universities and industry organizations. "The wealth of experience these distinguished individuals will bring to ZLB will allow us to continue our commitment to help the healthcare community improve the quality of lives for patients," Pete DeHart, president, ZLB Bioplasma Inc., said. "The panel's input will have a positive impact on both our immune-based products and the services we provide to our customers." About ZLB Bioplasma Inc. ZLB companies develop, manufacture and market biopharmaceutical products derived from human plasma. ZLB Bioplasma Inc. focuses on providing immune-based therapies and services that help the healthcare community improve the quality of life for their patients. ZLB's therapies, made from plasma collected from U.S. donors, are manufactured by the company's affiliate, ZLB Bioplasma AG, at its FDA-licensed facility in Bern, Switzerland. ZLB Bioplasma AG is a subsidiary of CSL Limited CSL Limited is an Australian-based manufacturer of medical products. Its products include various blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing. , a leading biotechnology and biopharmaceutical company founded in 1916 in Melbourne, Australia. CSL Limited acquired ZLB from the Swiss Red Swiss Re is the world’s largest reinsurer, now that it has acquired GE Insurance Solutions (Ligi 2006). Founded in 1863, Swiss Re now operates in more than 30 countries. General Electric owns 8.9% of the firm. Cross in August 2000. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion